VARTRIC-A
Composition:
VARTRIC-A 5/80 mg: Amlodipine 5 mg + Valsartan 80 mg.
VARTRIC-A 10/160 mg: Amlodipine 10 mg + Valsartan 160 mg.
Therapeutic Class:
Antihypertensive combination; Calcium Channel Blocker (CCB) + Angiotensin II Receptor Blocker (ARB).
Product Description:
VARTRIC-A is a fixed-dose combination of amlodipine and valsartan designed to help control high blood pressure through two complementary mechanisms. Amlodipine relaxes blood vessels, while valsartan blocks the effects of angiotensin II, helping reduce vascular resistance and blood pressure.
Indications:
VARTRIC-A is indicated for the treatment of essential hypertension in adults who require combination therapy to achieve adequate blood pressure control, as determined by a healthcare professional.
Clinical Benefits:
Provides complementary blood pressure-lowering effects, supports effective hypertension management, and offers convenient once-daily administration. A single-tablet combination may simplify the treatment regimen and support adherence to prescribed therapy.
Dosage and Administration:
VARTRIC-A is generally administered once daily, with or without food, according to the prescribed regimen. The 5/80 mg or 10/160 mg strength should be selected according to the patient's blood pressure, previous treatment, clinical response, and tolerability. Dose selection and adjustment must be guided by a qualified healthcare professional.
Warnings and Precautions:
Valsartan must not be used during pregnancy. Blood pressure, renal function, and serum potassium should be monitored when clinically indicated. Use under medical supervision.
Company: UNIMAX